Eva M Sevick-Muraca Selected Research

Neoplasm Metastasis (Metastasis)

4/2015	Deglycosylation of mAb by EndoS for improved molecular imaging.
2/2015	Preclinical characterization and validation of a dual-labeled trastuzumab-based imaging agent for diagnosing breast cancer.
1/2014	Spatio-temporal changes of lymphatic contractility and drainage patterns following lymphadenectomy in mice.
9/2012	Comparison of mAbs targeting epithelial cell adhesion molecule for the detection of prostate cancer lymph node metastases with multimodal contrast agents: quantitative small-animal PET/CT and NIRF.
2/2012	Imaging prostate cancer lymph node metastases with a multimodality contrast agent.
10/2010	Detection of Cancer Metastases with a Dual-labeled Near-Infrared/Positron Emission Tomography Imaging Agent.
1/2010	Near-Infrared Fluorescence Imaging in Humans with Indocyanine Green: A Review and Update.
7/2008	Near infrared fluorescent optical imaging for nodal staging.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Eva M Sevick-Muraca Research Topics

Disease

26	Neoplasms (Cancer) 04/2024 - 11/2003
9	Breast Neoplasms (Breast Cancer) 01/2023 - 11/2003
8	Lymphedema (Milroy Disease) 01/2023 - 05/2011
8	Neoplasm Metastasis (Metastasis) 04/2015 - 07/2008
6	Prostatic Neoplasms (Prostate Cancer) 04/2015 - 02/2012
5	Melanoma (Melanoma, Malignant) 10/2018 - 10/2004
3	Lymphatic Metastasis 08/2020 - 02/2012
3	Inflammation (Inflammations) 03/2014 - 01/2013
3	Heterotopic Ossification (Ectopic Ossification) 10/2011 - 12/2010
3	Kaposi Sarcoma (Kaposi's Sarcoma) 05/2005 - 10/2004
2	Carcinoma (Carcinomatosis) 04/2024 - 09/2012
2	Breast Cancer Lymphedema 01/2023 - 07/2010
2	Endocarditis 01/2017 - 04/2014
2	Wounds and Injuries (Trauma) 01/2016 - 07/2013
2	Infections 04/2014 - 03/2014
2	Glioma (Gliomas) 08/2010 - 07/2005
1	Head and Neck Neoplasms (Head and Neck Cancer) 04/2024
1	Venous Insufficiency 01/2021
1	Myocardial Infarction 01/2019
1	Ulcer 01/2016
1	Leg Ulcer 01/2016
1	Varicose Ulcer (Ulcer, Venous) 01/2016
1	Hypoplastic Left Heart Syndrome 10/2014
1	Pleural Effusion (Pleural Effusions) 10/2014
1	Lymphatic Diseases 01/2014
1	Lymphocele 05/2013
1	Hypertension (High Blood Pressure) 08/2012

Drug/Important Bio-Agent (IBA)

9	Indocyanine Green (Cardio-Green)FDA LinkGeneric 01/2021 - 03/2008
7	Contrast MediaIBA 01/2016 - 11/2003
5	Proteins (Proteins, Gene)FDA Link 01/2017 - 10/2011
5	Monoclonal AntibodiesIBA 01/2017 - 11/2003
4	Epithelial Cell Adhesion MoleculeIBA 02/2015 - 05/2012
4	Coloring Agents (Dyes)IBA 05/2013 - 10/2004
4	IRDye 800CWIBA 05/2012 - 03/2007
4	Fluorescent Dyes (Fluorescent Probes)IBA 07/2008 - 04/2005
4	ErbB Receptors (EGF Receptor)IBA 09/2007 - 11/2003
4	CY5.5 cyanine dyeIBA 03/2007 - 11/2003
3	CytokinesIBA 01/2023 - 01/2013
3	Biomarkers (Surrogate Marker)IBA 01/2023 - 09/2007
3	Trastuzumab (Herceptin)FDA Link 02/2015 - 09/2007
3	IRDye800IBA 02/2015 - 10/2004
3	human ERBB2 proteinIBA 02/2015 - 09/2007
3	Epidermal Growth Factor (EGF)IBA 07/2008 - 11/2003
3	IntegrinsIBA 07/2005 - 04/2005
2	Peptides (Polypeptides)IBA 04/2024 - 10/2004
2	Indicators and Reagents (Reagents)IBA 08/2020 - 09/2012
2	Vascular Endothelial Growth Factor CIBA 10/2018 - 07/2013
2	Pentetic Acid (DTPA)FDA LinkGeneric 02/2015 - 09/2007
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 07/2013 - 01/2013
2	fluorescent protein 583IBA 09/2012 - 02/2012
2	Hematoxylin (Haematoxylon)IBA 10/2010 - 09/2007
2	Eosine Yellowish-(YS) (Eosin)IBA 10/2010 - 09/2007
1	VaccinesIBA 04/2024
1	LigandsIBA 04/2024
1	Toll-Like Receptors (Toll-Like Receptor)IBA 04/2024
1	NanovaccinesIBA 04/2024
1	ChemokinesIBA 01/2023
1	AntigensIBA 04/2022
1	gallium arsenide (GaAs)IBA 08/2020
1	Matrix Metalloproteinases (MMPs)IBA 01/2019
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2018
1	Fimbriae Proteins (Pilin)IBA 01/2017
1	Polysaccharides (Glycans)IBA 04/2015
1	Glycoside Hydrolases (Endoglycosidases)IBA 04/2015
1	Immunoconjugates (Immunoconjugate)IBA 02/2015
1	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 02/2015
1	1- (1,3- carboxypropyl)- 4,7- carboxymethyl- 1,4,7- triazacyclononaneIBA 02/2015
1	AntibodiesIBA 04/2014
1	Peptidoglycan (Murein)IBA 04/2014
1	LipidsIBA 03/2014
1	Complement System Proteins (Complement)IBA 07/2013
1	SaltsIBA 08/2012
1	EstersIBA 05/2012
1	DOTA-NHSIBA 05/2012
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 10/2011
1	HydrogelsIBA 12/2010
1	Indium-111IBA 07/2008
1	Immunoglobulin G (IgG)IBA 09/2007
1	Integrin beta3 (GPIIIa)IBA 09/2005
1	arginyl-glycyl-aspartyl-phenylalanineIBA 09/2005
1	IndiumIBA 09/2005
1	Cyclic PeptidesIBA 09/2005
1	Integrin alphaVbeta3IBA 10/2004
1	Cetuximab (Erbitux)FDA Link 11/2003

Therapy/Procedure

8	Therapeutics 01/2019 - 11/2003
5	Radiotherapy 01/2023 - 03/2012
4	Lymph Node Excision (Lymph Node Dissection) 01/2023 - 12/2013
3	Intradermal Injections 01/2021 - 08/2010
2	Immunotherapy 04/2022 - 01/2019
2	Intravenous Administration 02/2015 - 01/2010
2	Manual Lymphatic Drainage 03/2012 - 05/2011
2	Intravenous Injections 05/2005 - 04/2005
1	Drug Therapy (Chemotherapy) 01/2023
1	Chest Tubes (Chest Tube) 10/2014
1	Pleurodesis 10/2014
1	Injections 12/2013
1	Microspheres (Microsphere) 12/2010
1	Subcutaneous Injections 07/2008